News Industry News IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly January 22, 2022
News Industry News Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease April 26, 2018
News Industry News Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension April 09, 2018
News Industry News Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease May 25, 2017
News Industry News Medtronic Receives IDE Approval to Initiate Study of IN.PACT® Admiral® Drug-Coated Balloon for a New Indication in Patients with End-Stage Renal Disease January 30, 2017
News Industry News Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin August 25, 2016
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Industry News Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters August 03, 2015
News Industry News First Clinical Cases Performed Using Lombard Medical's Aorfix(TM) Plus Endovascular Stent Graft July 01, 2015
News Industry News In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion May 29, 2015
News Industry News Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension September 16, 2014
News Industry News New Data Reinforce Significant Blood Pressure Reduction Sustained to Two Years Using the Symplicity™ Renal Denervation System March 09, 2013
News Industry News Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT October 22, 2012